CH540925A - Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten - Google Patents

Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten

Info

Publication number
CH540925A
CH540925A CH627569A CH627569A CH540925A CH 540925 A CH540925 A CH 540925A CH 627569 A CH627569 A CH 627569A CH 627569 A CH627569 A CH 627569A CH 540925 A CH540925 A CH 540925A
Authority
CH
Switzerland
Prior art keywords
preparation
new
oxadiazole derivatives
oxadiazole
derivatives
Prior art date
Application number
CH627569A
Other languages
German (de)
English (en)
Inventor
Kalman Dr Harsanyi
Jozsef Dipl Ing Reiter
Dezso Dipl Ing Korbonits
Casaba Dipl Ing Gonczi
Kalman Dipl Ing Takacs
Erzsebet Dipl Ing Bako
Gyorgy Dr Med Leszkovszky
Tardos Laszlo
Vertesy Csaba
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CH540925A publication Critical patent/CH540925A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH627569A 1968-04-26 1969-04-24 Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten CH540925A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000796 1968-04-26

Publications (1)

Publication Number Publication Date
CH540925A true CH540925A (de) 1973-08-31

Family

ID=10994349

Family Applications (2)

Application Number Title Priority Date Filing Date
CH627569A CH540925A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten
CH1476972A CH542232A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1476972A CH542232A (de) 1968-04-26 1969-04-24 Verfahren zur Herstellung neuer 1,2,4-Oxadiazol-Derivate

Country Status (15)

Country Link
US (1) US3647809A (https=)
JP (1) JPS4824394B1 (https=)
AT (2) AT292727B (https=)
BE (1) BE732131A (https=)
BR (1) BR6908381D0 (https=)
CA (1) CA954858A (https=)
CH (2) CH540925A (https=)
DE (1) DE1920037A1 (https=)
FR (1) FR2007529B1 (https=)
GB (1) GB1271302A (https=)
IL (1) IL31990A (https=)
NL (1) NL6906401A (https=)
NO (1) NO124253B (https=)
PL (1) PL79435B1 (https=)
SE (1) SE368576B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853893A (en) * 1973-04-02 1974-12-10 Squibb & Sons Inc Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
HU177086B (en) * 1975-06-09 1981-07-28 Eszakmagyar Vegyimuevek Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
EP1582519A3 (en) * 1999-08-19 2005-12-21 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
NZ517221A (en) * 1999-08-19 2004-01-30 Nps Pharma Inc Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CN1853630A (zh) * 2001-02-21 2006-11-01 Nps制药公司 杂多环化合物及其在亲代谢的谷氨酸受体拮抗剂中的应用
AU2003264018A1 (en) 2002-08-09 2004-02-25 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
WO2004091480A2 (en) * 2003-04-09 2004-10-28 Exelixis, Inc. Tie-2 modulators and methods of use
US20060252741A1 (en) * 2003-05-15 2006-11-09 Colandrea Vincent J 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
US20060189661A1 (en) * 2003-11-03 2006-08-24 Wagenen Bradford V Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005060961A2 (en) * 2003-12-18 2005-07-07 Astrazeneca Ab Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
JP4958560B2 (ja) * 2003-12-24 2012-06-20 プロシディオン・リミテッド Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
WO2005077368A2 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Treatment of gastro-esophageal reflux disease (gerd)
KR20080000622A (ko) * 2005-04-26 2008-01-02 뉴로서치 에이/에스 신규한 옥사디아졸 유도체 및 이의 의학적 용도
IL169855A (en) * 2005-07-25 2014-05-28 Elta Systems Ltd A system and method for locating a receiver location
AR058439A1 (es) 2005-07-26 2008-02-06 Portela & Ca Sa Derivados de nitrocatecol como inhibidores de comt. procesos de obtencion y composiciones farmaceuticas.
EP1845097A1 (en) * 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
TWI392671B (zh) * 2006-09-07 2013-04-11 Actelion Pharmaceuticals Ltd 吡啶-４-基衍生物
ES2400163T3 (es) * 2006-09-08 2013-04-08 Actelion Pharmaceuticals Ltd. Derivados de piridil-3-ilo como agentes de inmunomodulación
EP2481410B1 (en) 2007-01-31 2016-07-13 BIAL - Portela & Ca., S.A. Nitrocatechol derivates as COMT inhibitors administered with a specific dosage regime
PT2125797E (pt) * 2007-03-16 2014-03-11 Actelion Pharmaceuticals Ltd Derivados aminopiridina como agonistas do receptor s1p1/edg1
US8598208B2 (en) * 2007-08-17 2013-12-03 Actelion Pharmaceuticals Ltd. Pyridine derivatives as S1P1/EDG1 receptor modulators
WO2009108077A2 (en) * 2008-02-28 2009-09-03 Bial - Portela & Ca., S.A. Pharmaceutical composition for poorly soluble drugs
JP5411877B2 (ja) * 2008-03-06 2014-02-12 アクテリオン ファーマシューティカルズ リミテッド ピリジン化合物
HRP20130641T1 (en) * 2008-03-07 2013-08-31 Actelion Pharmaceuticals Ltd. Pyridin-2-yl derivatives as immunomodulating agents
KR20110002462A (ko) 2008-03-17 2011-01-07 바이알 - 포르텔라 앤드 씨에이 에스에이 5-[3-(2,5-디클로로-4,6-디메틸-1-옥시-피리딘-3-일)-[1,2,4]옥사디아졸-5-일]-3-나이트로벤젠-1,2-디올의 결정형
SI2291080T1 (sl) 2008-05-14 2015-11-30 The Scripps Research Institute Novi modulatorji sfingosinskih fosfatnih receptorjev
WO2010093650A2 (en) 2009-02-10 2010-08-19 Divergence, Inc. Compositions and methods for controlling nematodes
AU2010231961B2 (en) * 2009-04-01 2015-05-21 Bial - Portela & Ca., S.A. Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
RU2550133C2 (ru) * 2009-04-01 2015-05-10 БИАЛ-ПОРТЕЛА энд КА., С.А. Фармацевтические составы, включающие производные нитрокатехола, и способы их получения
CN102471328B (zh) 2009-07-16 2015-04-01 埃科特莱茵药品有限公司 吡啶-4-基衍生物
HRP20150919T1 (hr) 2011-01-19 2015-09-25 Actelion Pharmaceuticals Ltd. Derivati 2-metoksi-piridin-4-ila
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
WO2013089573A1 (en) 2011-12-13 2013-06-20 BIAL - PORTELA & Cª., S.A. Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
CA2901006A1 (en) * 2013-02-15 2014-08-21 Monsanto Technology Llc 3,5-disubstituted-4,5-dihydro-1,2,4-oxadiazoles for controlling nematode pests
JP2018500300A (ja) 2014-11-28 2018-01-11 ノヴィファーマ，エス．アー． パーキンソン病を遅延させるための医薬
BR112017024785B1 (pt) 2015-05-20 2022-05-17 Idorsia Pharmaceuticals Ltd Forma cristalina do composto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4] oxadiazol-3- il]-2-etil-6-metilfenoxi}-propano-1,2-diol, composição farmacêutica, e, uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL256329A (https=) * 1959-09-29
US3227725A (en) * 1962-04-17 1966-01-04 Union Carbide Corp Certain 3,5-disubstituted 1,2,4-oxadiazole compounds

Also Published As

Publication number Publication date
CA954858A (en) 1974-09-17
FR2007529A1 (https=) 1970-01-09
BE732131A (https=) 1969-10-01
DE1920037A1 (de) 1970-11-12
BR6908381D0 (pt) 1973-02-08
NO124253B (https=) 1972-03-27
PL79435B1 (en) 1975-06-30
AT292728B (de) 1971-09-10
CH542232A (de) 1973-11-15
US3647809A (en) 1972-03-07
NL6906401A (https=) 1969-10-28
JPS4824394B1 (https=) 1973-07-20
IL31990A0 (en) 1969-06-25
FR2007529B1 (https=) 1973-03-16
GB1271302A (en) 1972-04-19
SE368576B (https=) 1974-07-08
AT292727B (de) 1971-09-10
IL31990A (en) 1974-05-16

Similar Documents

Publication Publication Date Title
CH540925A (de) Verfahren zur Herstellung von neuen 1,2,4-Oxadiazol-Derivaten
AT283353B (de) Verfahren zur Herstellung von neuen N-Tritylimidazolderivaten
AT293389B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridin-Derivaten
AT287732B (de) Verfahren zur Herstellung von neuen Thioninderivaten
AT310184B (de) Verfahren zur Herstellung von neuen 1,3,4-Thiadiazolyl-(5)-harnstoffen
CH523269A (de) Verfahren zur Herstellung von neuen Imidazolidinochinazolinderivaten
AT310953B (de) Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten
CH510668A (de) Verfahren zur Herstellung von neuen 1,6-Dimethyl-10a-ergolinderivaten
AT286284B (de) Verfahren zur Herstellung von neuen 7-Cyan-cumarinderivaten
AT289307B (de) Verfahren zur Herstellung von neuen 4,6-Dichlor-4,6-östradienen
CH532077A (de) Verfahren zur Herstellung von neuen basischen Derivaten des Benzoxazolin-2-ons
AT288380B (de) Verfahren zur Herstellung von neuen Oxadiazolderivaten
AT293358B (de) Verfahren zur Herstellung von neuen N-Acyl-hydroxylaminderivaten
CH505829A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkylbenzolsulfonamids
AT296970B (de) Verfahren zur Herstellung von neuen Derivaten der 2,3-Dialkyl-4-phenyl-cyclohexencarbonsäure
CH555359A (de) Verfahren zur herstellung von neuen 3-(pyrazolyl-(1))-7(v-triazolyl-(2))-cumarinen.
AT287734B (de) Verfahren zur Herstellung von neuen heterocyhclischen N,N'-Diglycidylverbindungen
AT294791B (de) Verfahren zur Herstellung von neuen Cysteamin-Derivaten
AT291253B (de) Verfahren zur Herstellung von neuen 1,3,4-Thiadiazolderivaten
AT294105B (de) Verfahren zur Herstellung von neuen 2-Hydroxymethyl-3-carbonsäureamido-chinoxalin-di-N-oxyden(1,4)
AT291267B (de) Verfahren zur Herstellung von neuen heterocyclischen N,N'-Diglycidylverbindungen
CH513110A (de) Verfahren zur Herstellung von neuen Bis-alkanolamin-Derivaten
AT283356B (de) Verfahren zur Herstellung von neuen 1,2,4-Oxdiazolidin-Derivaten
AT281816B (de) Verfahren zur Herstellung von neuen 1,2-Benzixothiazol-Derivate
CH518941A (de) Verfahren zur Herstellung von neuen 3,5-Dioxopyrazolidinderivaten

Legal Events

Date Code Title Description
PL Patent ceased